Towards faster and more economical drug development

Robert Soliva and Modesto Orozco with their team (César Rangel)
Robert Soliva and Modesto Orozco with their team (César Rangel)

La Vanguardia has devoted an article to the Senén Vilaró Prize for the best innovative company, which has recently been awarded to Nostrum Biodiscovery (NBD). This prize acknowledges the capacity of the technology developed by this company to allow pharmaceutical companies to speed up drug discovery and reduce the costs involved.

NBD was founded in 2016 as a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), with the objective to support the discovery and launch of new drugs and biotech molecules. Modesto Orozco, head of Molecullar Modelling and Bioinformatics lab and holder of an ERC Advanced Grant at IRB Barcelona, is one of the founders of this company.

Link to: La Vanguardia

 

 

Documents: